Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 2/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | NSD3 | Q9BZ95 | 1/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15384357 | 0.75 | LMNA (0.37) | LMNAADORA2AADORA2BADORA1 | |
| SCHEMBL17761950 | 0.70 | GDA (0.33) | GDACYP3A4PMP22ALDH1A1LMNA | |
| SCHEMBL20011085 | 0.69 | GDA (0.32) | GDACYP3A4PMP22ALDH1A1LMNA | |
| SCHEMBL10104855 | 0.69 | GDA (0.32) | GDASRCCYP3A4PMP22ALDH1A1 | |
| SCHEMBL21987948 | 0.67 | DRD4 (0.43) | ALDH1A1TSHR | |
| SCHEMBL13177050 | 0.62 | GDA (0.32) | GDASRCCYP3A4PMP22ALDH1A1 | |
| SCHEMBL21586265 | 0.61 | ALDH1A1 (0.30) | GDAALDH1A1 | |
| SCHEMBL24079417 | 0.60 | GDA (0.30) | GDA | |
| SCHEMBL21678165 | 0.58 | CDC7 (0.40) | — | |
| SCHEMBL279754 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10568921-B1 | Extract of Vicia faba beans | KING SAUD UNIVERSITY (SA) | 2020-02-25 | — | — | US | disclosed |
| US-10300100-B1 | Extract of Vicia faba beans | KING SAUD UNIVERSITY (SA) | 2019-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10568921-B1 | Extract of Vicia faba beans | VPS26A, HRH3, ARCN1 | GDA 2632/4885SRC 2357/4885CYP3A4 1041/4885 |
| US-10300100-B1 | Extract of Vicia faba beans | VPS26A, HRH3, ARCN1 | GDA 2632/4885SRC 2357/4885CYP3A4 1041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.